Xavier Matías‐Guiu

机构：Instituto de Salud Carlos III, Bellvitge University Hospital, Hospital Universitari Arnau de Vilanova, Centre for Biomedical Network Research on Rare Diseases, Instituto de Investigación Biomédica de Lleida, Centro de Investigación Biomédica en Red de Cáncer, Medical Research Network · ORCID：0000-0002-7201-6605

发表论文 858 篇 · 总被引 32292 次 · h-index 86

代表论文

• ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025 (2025 · The Lancet Oncology · 被引 302)
• Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis (2025 · Nature Communications · 被引 46)
• Digital transformation of pathology - the European Society of Pathology expert opinion paper (2025 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 被引 40)
• Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer (2024 · Gynecologic Oncology · 被引 31)
• Implementing digital pathology: qualitative and financial insights from eight leading European laboratories (2025 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 被引 28)
• Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics (2024 · European Journal of Cancer · 被引 24)